Bristol-Myers Squibb (BMY) | Stock Overview & Key Data

Bristol-Myers Squibb Company | Healthcare

$49.97

1.98%

| Bristol-Myers Squibb Stock Comparison:

Bristol-Myers Squibb vs Eli Lilly and Bristol-Myers Squibb vs Johnson & Johnson Bristol-Myers Squibb vs Merck & Co Bristol-Myers Squibb vs Amgen Bristol-Myers Squibb vs Gilead Sciences Bristol-Myers Squibb vs S&P 500 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Bristol-Myers Squibb Performance Comparison

Loading chart data...

Bristol-Myers Squibb

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $49.12 High: $50.62

on June 10, 2025

52 Week Range

Low: $39.35 High: $63.33

on July 5, 2024

on March 11, 2025

All-Time High: $81.44 on November 28, 2022

Key Statistics

Market Cap i $98.5B

EPS i 2.68

P/E Ratio (TTM) i 18.06

Forward P/E i 6.89

P/B Ratio i 5.67

PEG Ratio i 6.89

Div. Yield i 4.88%

ROE i 31.99%

Beta i 0.386

Debt to Equity i 293.85

Financial Highlights

Profitability

Gross Margin i 72.92%

Operating Margin i 31.57%

Profit Margin i 11.38%

Returns and Earnings

Return on Assets (TTM) i 7.24%

Return on Equity (TTM) i 31.99%

EBITDA i $16.6B

Net Income (TTM) i $5.4B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i $2.48

Estimated Dividend Yield i 4.96%

5 Year Average Dividend Yield i 3.59%

Last 12-Month Dividend Yield i 4.88%

Last 12-Month Dividend i $2.44

% of Earnings Paid as Dividends i 91.04%

Dividend Date i May 1, 2025

Ex-Dividend Date i April 4, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Bristol-Myers Squibb BMY	98.52B Large-cap	3.91%	3.72%	-20.82%	-14.02%	-12.01%	21.33%	-32.24%	-11.38%
Eli Lilly and LLY	687.38B Mega-cap	7.51%	6.83%	-2.72%	0.95%	3.74%	-8.08%	177.58%	404.86%
Johnson & Johnson JNJ	369.72B Mega-cap	1.31%	1.50%	-6.71%	4.84%	8.63%	7.53%	-7.65%	8.81%
Merck & Co MRK	194.91B Large-cap	5.46%	1.14%	-14.58%	-19.46%	-17.97%	-37.14%	-3.82%	9.50%
Amgen AMGN	156.11B Large-cap	1.33%	6.80%	-10.36%	6.41%	13.17%	-1.72%	25.03%	22.95%
Gilead Sciences GILD	137.40B Large-cap	0.70%	6.04%	-6.07%	19.22%	19.82%	69.20%	88.07%	42.09%

Ownership & Short Interest

Insider Ownership i 0.07%

Institutional Ownership i 82.23%

Shares Short i 37M

Short Ratio i 2.07

Short % of Shares Outstanding i 1.82%

Average 10-Day Volume i 12M

Average 90-Day Volume i 15M

Bristol-Myers Squibb Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bristol-Myers Squibb would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is BMY's 52-week high and low?

In the last 52 weeks, Bristol-Myers Squibb reached a high of $63.33 (on March 11, 2025) and a low of $39.35 (on July 5, 2024).

What is the market cap and P/E ratio for BMY?

Curious about Bristol-Myers Squibb's size and valuation? Its market capitalization stands at 98.52B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.06, and the forward P/E (looking ahead) is 6.89.

Does BMY pay dividends? If so, what's the yield?

Yes, Bristol-Myers Squibb is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 4.88%, and the company is expected to pay out $2.48 per share over the coming year.

Who are Bristol-Myers Squibb's main competitors or similar companies to consider before investing?

When looking at Bristol-Myers Squibb, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Eli Lilly and LLY	687.38B	Healthcare	Drug Manufacturers - General	-8.08%	177.58%
Johnson & Johnson JNJ	369.72B	Healthcare	Drug Manufacturers - General	7.53%	-7.65%
Merck & Co MRK	194.91B	Healthcare	Drug Manufacturers - General	-37.14%	-3.82%
Amgen AMGN	156.11B	Healthcare	Drug Manufacturers - General	-1.72%	25.03%
Gilead Sciences GILD	137.40B	Healthcare	Drug Manufacturers - General	69.20%	88.07%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Bristol-Myers Squibb Company? (e.g., ROE, Debt/Equity)

To get a sense of Bristol-Myers Squibb's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 31.99%, the Debt to Equity ratio from the most recent quarter is 293.85, and its Gross Profit Margin stands at 72.92%.

What is the recent revenue and earnings growth for BMY?

Looking at Bristol-Myers Squibb's growth, its revenue over the trailing twelve months (TTM) was $48B. Compared to the same quarter last year (YoY), quarterly revenue grew by -5.60%, and quarterly earnings saw a YoY growth of -5.60%.

How much of BMY stock is held by insiders and institutions?

Wondering who owns Bristol-Myers Squibb stock? Company insiders (like executives and directors) hold about 0.07% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 82.23%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.